Immunotherapy

Immunotherapy is a cancer treatment that harnesses and strengthens the body's own immune system to recognise and destroy cancer cells, rather than directly attacking the cancer with chemicals or radiation. Checkpoint inhibitor drugs, the most common class used, work by blocking proteins that cancer cells exploit to hide from immune detection, effectively releasing the brakes on the immune response. It has transformed treatment for several cancer types, including melanoma, lung cancer and certain lymphomas, sometimes producing durable, long-lasting responses even in advanced disease. Treatment is given intravenously in cycles, with ongoing monitoring for both effectiveness and characteristic immune-related side effects.

Immunotherapy is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Medical Oncology specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is Cycles every 2-4 weeks, ongoing. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes There is no procedural recovery period beyond the infusion itself, though treatment typically continues for months to years depending on response and tolerability. Most patients resume normal activities the same day, with fatigue being the most common lingering symptom. Regular monitoring throughout treatment helps catch and manage immune-related side effects early, which can arise at any point during therapy.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

Immunotherapy has a documented success rate of Varies widely, 20-50% durable response in eligible cancers at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.